A Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients of China With HER2-positive Unresectable or Metastatic Breast Cancer
Clinical trial NCT05769751 · COMPLETED
Trial details
- NCT number
- NCT05769751
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-15
- Primary completion
- 2023-07-25
- Enrollment
- 865
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.